Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.

NCT04258072 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer

Interventions

DRUG: Vactosertib

Sponsor

Samsung Medical Center